NCT03736980View on ClinicalTrials.gov

Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 1, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Healthy
Interventions
DRUG

Placebo

100% lactose

DRUG

Psilocybine

Study Group 1: 0.250 mg/Kg weight Study Group 2: 0.200 mg/Kg body weight Study Group 3: 0.215 mg/Kg body weight Study Group 4: 0.315 mg/Kg body weight

All Listed Sponsors
lead

University of Zurich

OTHER

NCT03736980 - Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self | Biotech Hunter | Biotech Hunter